Serious adverse events experienced by patients with chronic heart failure taking spironolactone
Open Access
- 1 April 2001
- Vol. 85 (4) , 8e-8
- https://doi.org/10.1136/heart.85.4.e8
Abstract
In patients with chronic heart failure, spironolactone added to conventional treatment may lead to serious and, occasionally, fatal hyperkalaemia. In some cases this seems to happen because spironolactone causes diarrhoea. Four cases involving men with New York Heart Association functional class III heart failure are presented. As these cases revealed, close monitoring of blood chemistry is mandatory after starting spironolactone, and patients should be advised to stop spironolactone immediately if diarrhoea develops.Keywords
This publication has 3 references indexed in Scilit:
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Consequences of fluid loss in patients treated with ACE inhibitorsPublished by Oxford University Press (OUP) ,1987
- Hyperkalemia and hyporeninemic hypoaldosteronismKidney International, 1980